VEGFA and neoplasm: The paper demonstrated delivery of vascular endothelial growth factor and placental growth factor targeted siRNA via polyethylene glycol-based nanoparticles and reported efficient silencing of both the targeted genes and reversal of tumor microenvironment from pro-oncogenic to antitumoral (Wang et al., 2021).